MUC13: A Potential Cancer Treatment and Biomarker (G56667)
MUC13: A Potential Cancer Treatment and Biomarker
MUC13, also known as Mucin 13, is a protein that is expressed in various tissues throughout the body, including the skin, gut, and respiratory tract. It is a member of the mucin family, which is a group of glycoproteins that are involved in the production of mucin secretions in the body.
One of the things that makes MUC13 an interesting protein is its role in cancer. Studies have shown that high levels of MUC13 are often associated with the development and progression of various types of cancer, including colon cancer.
One reason for the link between MUC13 and cancer is that the protein can serve as a drug target. Researchers are interested in using MUC13 as a target for new cancer treatments because they believe that targeting this protein may have several advantages over other potential targets.
One of the key reasons for the interest in MUC13 as a drug target is its location on the body. MUC13 is primarily expressed in the gut, which makes it an attractive target for drugs that can disrupt its function and disrupt the growth of cancer cells that have taken hold in the gut.
Another reason for the interest in MUC13 is its role in cell signaling. MUC13 is a signaling molecule that is involved in a number of different processes in the body, including the regulation of cell growth and the immune response. Researchers believe that targeting MUC13 with drugs that can disrupt its function may be an effective way to treat cancer.
In addition to its potential as a drug target, MUC13 is also being studied as a potential biomarker for cancer. Studies have shown that MUC13 levels are often elevated in the gut, which makes it an attractive candidate for use as a biomarker for cancer.
Overall, MUC13 is an interesting protein that is being studied as a potential drug target and biomarker for cancer. Its role in cell signaling and its location on the body make it an attractive target for new treatments. Further research is needed to fully understand the potential of MUC13 as a cancer treatment and biomarker.
Protein Name: Mucin 13, Cell Surface Associated
Functions: Epithelial and hemopoietic transmembrane mucin that may play a role in cell signaling
The "MUC13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MUC13 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MUC15 | MUC16 | MUC17 | MUC19 | MUC2 | MUC20 | MUC20P1 | MUC21 | MUC22 | MUC3A | MUC3B | MUC4 | MUC5AC | MUC5B | MUC6 | MUC7 | MUC8 | Mucin | MUCL1 | MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex | MUPP | MUS81 | Muscarinic Acetylcholine Receptor (mAChR) | MUSK | MUSTN1 | MUTYH | MVB12A | MVB12B | MVD | MVK | MVP | MX1 | MX2 | MXD1 | MXD3 | MXD4 | MXI1 | MXRA5 | MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15 | MYH16 | MYH2 | MYH3 | MYH4 | MYH6 | MYH7 | MYH7B | MYH8 | MYH9 | MYHAS | MYL1 | MYL10 | MYL11 | MYL12A | MYL12B | MYL12BP3 | MYL2 | MYL3 | MYL4
